WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009061395) HCV COMBINATION THERAPIES COMPRISING VX-950, PEG-IFN AND RIBAVIRIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/061395    International Application No.:    PCT/US2008/012460
Publication Date: 14.05.2009 International Filing Date: 04.11.2008
IPC:
A61K 31/7056 (2006.01), A61K 38/21 (2006.01), A61P 31/12 (2006.01)
Applicants: VERTEX PHARMACEUTICALS INCORPORATED [US/US] (For All Designated States Except US).
MCNAIR, Lindsay [US/US]; (US) (For US Only)
Inventors: MCNAIR, Lindsay; (US)
Agent: O'BRIEN, Jonathan, P.; Honigman Miller Schwartz and Cohn LLP 350 East Michigan Avenue, Suite 300 Kalamazoo, Michigan 49007-3800 (US)
Priority Data:
60/985,522 05.11.2007 US
61/085,145 31.07.2008 US
61/109,690 30.10.2008 US
Title (EN) HCV COMBINATION THERAPIES COMPRISING VX-950, PEG-IFN AND RIBAVIRIN
(FR) THÉRAPIES DE COMBINAISON DU VHC
Abstract: front page image
(EN)The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of Latino and African American patients infected with HCV using the combination therapy.
(FR)L'invention porte sur des thérapies de combinaison pour le traitement du virus de l'hépatite C par le telaprévir et un interféron alfa-2a PEGylé avec ou sans ribavirine. L'invention porte sur le traitement de patients latino-américains et afro-américains infectés par le VHC à l'aide de la thérapie de combinaison.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)